APA

Enaida H., Hirakata A., Ohji M., Nishida K., Kubota T., Ogata N., Sonoda K., Uchiyama M., Kishimoto J., Todaka K., Nakanishi Y. & Ishibashi T. (20161213). [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial]. : Nippon Ganka Gakkai zasshi.

Chicago

Enaida Hiroshi, Hirakata Akito, Ohji Masahito, Nishida Kohji, Kubota Toshiaki, Ogata Nahoko, Sonoda Koh-Hei, Uchiyama Makiko, Kishimoto Junji, Todaka Koji, Nakanishi Yoichi and Ishibashi Tatsuro. 20161213. [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial]. : Nippon Ganka Gakkai zasshi.

Harvard

Enaida H., Hirakata A., Ohji M., Nishida K., Kubota T., Ogata N., Sonoda K., Uchiyama M., Kishimoto J., Todaka K., Nakanishi Y. and Ishibashi T. (20161213). [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial]. : Nippon Ganka Gakkai zasshi.

MLA

Enaida Hiroshi, Hirakata Akito, Ohji Masahito, Nishida Kohji, Kubota Toshiaki, Ogata Nahoko, Sonoda Koh-Hei, Uchiyama Makiko, Kishimoto Junji, Todaka Koji, Nakanishi Yoichi and Ishibashi Tatsuro. [Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial]. : Nippon Ganka Gakkai zasshi. 20161213.